AzTrials
AzTrials

Shoulder Adhesive CapsulitisNCT04782349

Mulligan Mobilization With Laser for Shoulder Adhesive Capsulitis

A study testing mulligan mobilization with low level laser therapy and traditional physical therapy exercises, low level laser therapy and traditional physical therapy exercises and physical therapy exercises in people with Shoulder Adhesive Capsulitis, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Adhesive capsulitis (frozen shoulder) is a condition of uncertain etiology characterized by pain and progressive loss of both active and passive shoulder motion. Shoulder pain and stiffness are accompanied by disability. It is thought that the incidence is 3 to 5% in the general population. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Shoulder Adhesive Capsulitis
What is being tested?
mulligan mobilization with low level laser therapy and traditional physical therapy exercises, low level laser therapy and traditional physical therapy exercises and physical therapy exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteEgypt
Study dates
15 Dec 2021to 15 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • The participant selected for the study were patients (both male and female).
  • Subjects diagnosed diagnosed by physicians with Magnetic Resonance Imaging (MRI).
  • \& referred by an Orthopedician with stage 2 Adhesive Capsulitis.
  • Age group of 40-60 years of old.
  • painful condition of at least 3 months with 50% restriction in passive shoulder flexion, abduction and external rotation, in a sagittal plane compared with opposite side.
  • The severity of pain on visual analogue scale was higher than three out of ten, pain aggravated by movements.
  • patients were suffering from pain and limitation in the motion for more than 3 month.

Who cannot join

  • Patients with any shoulder injury or trauma, surgical release of capsule.
  • Previous manipulation done under anaesthesia of the affected shoulder in the preceding 4 weeks.
  • Other conditions involving the shoulder (eg. rheumatoid arthritis, osteoarthritis, damage of the glenohumeral cartilage, osteoporosis, or malignancies in the shoulder region).
  • Pain or disorders of the cervical spine, elbow, wrist, or hand.
  • Presence of medical conditions such as cardiac disease, infections, coagulation disorder.
  • patients having any intra articular injection, or physiotherapy treatment in the affected shoulder during the last three months.
Show all 10Show fewer
  • patients with musculoskeletal disorder (any type of fracture), any history of surgery on that shoulder and patients with tendon calcification, patients with cervical rib, rotator cuff tear patients.
  • Patients have insulin-dependent diabetes mellitus.
  • Bilateral Frozen Shoulder
  • systemic inflammatory joint disease (such as rheumatoid arthritis or polymyalgia rheumatica).

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Physical Therapy, Cairo University

    Giza, 12613

Other trials in Egypt

About this study

Official title: Additive Effect of Mulligan Mobilization With Low Level Laser Therapy for Treatment of Patients With Shoulder Adhesive Capsulitis: Double Blinded, Randomized Controlled Trial.

Adhesive capsulitis (frozen shoulder) is a condition of uncertain etiology characterized by pain and progressive loss of both active and passive shoulder motion.

Shoulder pain and stiffness are accompanied by disability. It is thought that the incidence is 3 to 5% in the general population. Laser therapy is widely used for treating different musculoskeletal diseases, because of its ability to reduce pain and improve the physical function. Also, MWM when used for shoulders with limited range of motion because of pain had shown improvement in range of motion and pressure pain threshold. Previous studies have investigated the efficacy of combining different manual technique with LLLT for treating pain in some body parts. However, up till now the combined effect of MWM with LLLT for treatment of patients with shoulder adhesive capsulitis have not been investigated.

So, the present randomized controlled study will be conducted to investigate the effect of adding mulligan mobilization with movement to low level laser therapy in treatment of patients with shoulder adhesive capsulitis.

Being tested
mulligan mobilization with low level laser therapy and traditional physical therapy exercises, low level laser therapy and traditional physical therapy exercises, physical therapy exercises
Medical subject headings
Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mulligan mobilization with low level laser therapy and traditional physical therapy exercisesOther

    for mulligan mobilization: for improving the limited range of motion of shoulder joint, the therapist will apply posterolateral mobilization for the shoulder joint. Three sets of painless glides of 10 repetitions will be applied with a rest interval of 30 s between each set.

    For low level laser application: Laser specifications is as follows: 850 nm wave length and pulsed application with 8 W applied for 20 minutes. laser will be applied over painful points of the shoulder.

    For traditional physical therapy exercises: the patients will receive the following exercise program: self stretching exercises for shoulder joint, pully exercises, back climbing exercises, finger ladder exercises, circumduction exercises and pendulum exercises

  • low level laser therapy and traditional physical therapy exercisesOther

    patients in this group will receive low level laser and traditional physical exercises as described before for group (A)

  • physical therapy exercisesOther

    The patients will receive traditional physical therapy exercises only as described before for group (A)

Study groups in NCT04782349
Study groupRoleWhat they receive
high intensity laser groupExperimentalNot described
Receives: Other: mulligan mobilization with low level laser therapy and traditional physical therapy exercises
low intensity laser groupExperimentalNot described
Receives: Other: low level laser therapy and traditional physical therapy exercises
control groupOtherNot described
Receives: Other: physical therapy exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Pain intensity will be measured with Visual Analog Scale (VAS). The patient will be asked to mark the severity of pain on a 100-mm line with "no pain" on one end and "most unbearable pain" on the other end

    Measured: change from base line at three weeks

Secondary outcomes (3)
  1. pain pressure threshold

    • The most sensitive point will be located over the anterior aspect of the shoulder by manual palpation and will be marked with a permanent marker so that the same point could be used for pre- and post-condition application measures. This process will be repeated three times with a 30-s rest period between each measurement.

    Measured: change from baseline at three weeks

  2. Shoulder range of motion (flexion, abduction, and external rotation)

    A universal goniometer will be used to measure the ROM.

    • patient in supine lying with shoulder neutral.
    • Flexion ROM will be measured with the stationary arm of goniometer parallel to the trunk, and the moving arm parallel with the affected arm. Fulcrum will be placed in the point of lateral aspect of acromion process.
    • For measurement of shoulder abduction, the fulcrum of the goniometer will be placed anterior to acromion process, stationary arm parallel to midline of sternum and movable arm will be placed at the midline of humerus. The patient is asked to abduct the arm as much as possible and the reading of the goniometer will be noted.
    • For external rotation of the shoulder, patient is positioned in supine lying and arm abducted to 90 degree and elbow at 90 degree. Fulcrum of goniometry over olecranon and stationary arm perpendicular to floor, moving arm is aligned parallel to the ulna. The patient is asked to rotate externally as much as possible.

    Measured: change from baseline at three weeks

  3. Disability of Arm Shoulder Hand (DASH):

    • The functional index designed to determine the symptoms and limitations that participant was experiencing while performing daily activities. This scale consists of 30 items in the form of activities of daily living with each item scoring from 0 to 4, where 0 is no difficulty in performing that activity and 4 is unable to do that activity. The DASH score is expressed as a percentage.

    Measured: change from baseline at three weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2021
  2. Study start15 Dec 2021
  3. Primary completion25 Jul 2022
  4. Study completion15 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04782349
Sponsor's protocol ID
Treatment of frozen shoulder
Status last verified
Mar 2021
First submitted
1 Mar 2021
Last updated
25 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lirio Romero C, Torres Lacomba M, Castilla Montoro Y, Prieto Merino D, Pacheco da Costa S, Velasco Marchante MJ, Bodes Pardo G. Mobilization With Movement for Shoulder Dysfunction in Older Adults: A Pilot Trial. J Chiropr Med. 2015 Dec;14(4):249-58. doi: 10.1016/j.jcm.2015.03.001. Epub 2015 Nov 24.

    PubMed 26793036
  • Noten S, Meeus M, Stassijns G, Van Glabbeek F, Verborgt O, Struyf F. Efficacy of Different Types of Mobilization Techniques in Patients With Primary Adhesive Capsulitis of the Shoulder: A Systematic Review. Arch Phys Med Rehabil. 2016 May;97(5):815-25. doi: 10.1016/j.apmr.2015.07.025. Epub 2015 Aug 15.

    PubMed 26284892
  • Ip D, Fu NY. Two-year follow-up of low-level laser therapy for elderly with painful adhesive capsulitis of the shoulder. J Pain Res. 2015 May 25;8:247-52. doi: 10.2147/JPR.S84376. eCollection 2015.

    PubMed 26045677

Questions about this trial

What is this clinical trial studying?

A study testing mulligan mobilization with low level laser therapy and traditional physical therapy exercises, low level laser therapy and traditional physical therapy exercises and physical therapy exercises in people with Shoulder Adhesive Capsulitis, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: change from base line at three weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04782349, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in